Results 251 to 260 of about 391,709 (316)
Inhibitory effects of the selective μ-opioid receptor antagonist UD-030 on methamphetamine-induced conditioned place preference. [PDF]
Neuropsychopharmacol RepIde S +5 more
europepmc +1 more source
Radiotherapy Plus the Neurokinin-1 Receptor Antagonist Aprepitant: A Potent Therapeutic Strategy for the Treatment of Diffuse Intrinsic Pontine Glioma. [PDF]
Cancers (Basel)Muñoz M, Rosso M.
europepmc +1 more source
The glutamate receptor antagonist ifenprodil inhibits hepatitis E virus infection. [PDF]
Antimicrob Agents ChemotherKlöhn M +6 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Vasopressin-Receptor Antagonists
Future Cardiology, 2010Despite a crucial role in body fluid homeostasis, elevated vasopressin levels can also be pathological in conditions such as congestive heart failure, liver cirrhosis and the syndrome of inappropriate antidiuretic hormone secretion. The result of elevated vasopressin is renal water retention and hyponatremia, a low serum sodium concentration ...
Ewout J. Hoorn, Robert Zietse
openaire +3 more sources
Melanocortins and their Receptors and Antagonists
Current Drug Targets, 2003The melanocortins are a group of small protein hormones derived by post-translational cleavage of the proopiomelanocortin (POMC) gene product. The known melanocortin hormones include alpha-melanocyte stimulating hormone (MSH), beta-MSH, gamma-MSH and adrenocorticotropic hormone (ACTH).
Voisey, J, Carroll, L, van Daal, A
openaire +4 more sources
Pharmaceutical Patent Analyst, 2012
The orexin neuropeptides bind to two G protein-coupled receptors, orexin-1 and -2. Small-molecule antagonism of the receptors has potential therapeutic utility in a number of areas, most notably insomnia, for which the most advanced dual orexin receptor antagonist has now completed clinical trials.
Miles Congreve +4 more
openaire +3 more sources
The orexin neuropeptides bind to two G protein-coupled receptors, orexin-1 and -2. Small-molecule antagonism of the receptors has potential therapeutic utility in a number of areas, most notably insomnia, for which the most advanced dual orexin receptor antagonist has now completed clinical trials.
Miles Congreve +4 more
openaire +3 more sources
Receptors for calcium antagonists
The American Journal of Cardiology, 1988Calcium antagonists have been divided into 3 different subclasses represented by nifedipine, verapamil and diltiazem. These drugs have different pharmacologic effects and are not interchangeable. Previous studies suggested that all calcium antagonists bind to a 170 kd polypeptide (now called the alpha 2 subunit of the voltage-dependent calcium channel).
Edward McKenna +2 more
openaire +3 more sources